Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,850.00    155.00 (2.32%)
Bid:
6,845.00
Ask:
6,855.00
Spread: 10.00 (0.146%)
Market Cap: £5.06b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Future Board Change

30 Jan 2024 11:15

RNS Number : 2847B
Spirax-Sarco Engineering PLC
30 January 2024
 

 

 

 

30th January 2024

 

FUTURE BOARD CHANGE

 

 

In accordance with the Listing Rule requirement to give notice of new directorships held by current directors (LR 9.6.14 (2)), Spirax-Sarco Engineering plc announces that Jamie Pike, Chair of the Board and Non-Executive Director, will be appointed as Chair and Non-Executive Director of IMI plc with effect from 1st January 2025.

 

The Board of Spirax-Sarco Engineering plc previously announced that Jamie would step down as Chair and Non-Executive Director during 2024, following the expiry of his nine years as a Director. A process to appoint his successor is well advanced.

 

The Board is satisfied that Jamie's appointment with IMI plc complies with the UK Corporate Governance Code 2018 and proxy advisor guidelines.

 

 

Enquiries:

 

Andy Robson, General Counsel

Tel: 01242 535276

 

 

About Spirax?Sarco Engineering plc

Spirax?Sarco Engineering plc is a leading global thermal energy management and fluid technology solutions Group. It comprises three world?leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both businesses help their customers improve process efficiencies, meet environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson?Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham (UK), has 40 strategically located manufacturing plants around the world and employs more than 10,000 people, including more than 2,100 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good Indexes.

 

 

Further information can be found at spiraxsarcoengineering.com

 

RNS filter: Inside Information prior to release

LEI 213800WFVZQMHOZP2W17

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUAAGUPCGRB
Date   Source Headline
25th May 201210:00 amRNSResult of AGM
22nd May 20123:20 pmRNSDirector/PDMR Shareholding
16th May 20124:45 pmRNSRe-Appointment of Non-Executive Directors
16th May 20129:13 amRNSHolding(s) in Company
15th May 20127:00 amRNSInterim Management Statement
10th May 20123:01 pmRNSHolding(s) in Company
9th May 20129:57 amRNSHolding(s) in Company
1st May 20125:03 pmRNSTotal Voting Rights
26th Apr 20123:02 pmRNSDirector/PDMR Shareholding
23rd Apr 20128:41 amRNSHolding(s) in Company
17th Apr 20122:56 pmRNSDirector/PDMR Shareholding
17th Apr 20122:14 pmRNSDirector/PDMR Shareholding
12th Apr 20128:33 amRNSHolding(s) in Company
2nd Apr 201210:05 amRNSHolding(s) in Company
27th Mar 201210:44 amRNSHolding(s) in Company
20th Mar 20125:16 pmRNSHolding(s) in Company
15th Mar 201211:00 amRNSDirector/PDMR Shareholding
15th Mar 20127:00 amRNSDirectorate Change
14th Mar 20125:17 pmRNSDirector/PDMR Shareholding
8th Mar 20127:00 amRNSPreliminary Results
1st Mar 201210:38 amRNSTotal Voting Rights
22nd Feb 20129:11 amRNSHolding(s) in Company
16th Feb 20129:09 amRNSHolding(s) in Company
8th Feb 20128:39 amRNSHolding(s) in Company
1st Feb 20121:39 pmRNSTotal Voting Rights
16th Jan 20124:49 pmRNSNotice of Results
3rd Jan 20128:53 amRNSTotal Voting Rights
19th Dec 20119:11 amRNSRe-Appointment of Non-Executive Director
12th Dec 20114:25 pmRNSDirector/PDMR Shareholding
16th Nov 20115:31 pmRNSDirector/PDMR Shareholding
4th Nov 20117:00 amRNSInterim Management Statement
1st Nov 20114:27 pmRNSTotal Voting Rights
19th Oct 201112:00 pmRNSDirectorate Change
18th Oct 20119:28 amRNSHolding(s) in Company
17th Oct 20111:58 pmRNSHolding(s) in Company
12th Oct 20113:51 pmRNSDirector/PDMR Shareholding
11th Oct 20114:15 pmRNSTotal Voting Rights
6th Sep 20119:00 amRNSTotal Voting Rights
5th Sep 20115:02 pmRNSDirector/PDMR Shareholding
24th Aug 20114:28 pmRNSDirector/PDMR Shareholding
23rd Aug 20113:54 pmRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNS2011 Half Year Results
4th Aug 20115:32 pmRNSNotice of Results
4th Aug 20114:11 pmRNSTotal Voting Rights
27th Jul 20111:03 pmRNSAdditional Listing
12th Jul 20115:14 pmRNSDirector/PDMR Shareholding
6th Jul 20111:47 pmRNSAdditional Listing
1st Jul 201110:43 amRNSTotal Voting Rights
22nd Jun 20114:05 pmRNSDirector/PDMR Shareholding
9th Jun 20119:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.